NFKB1 and adult T-cell leukemia/lymphoma: Over time, such mutations may inactivate tumor-suppressor genes or disrupt regulatory feedback within the IKK/NF-κB pathway, promoting the development of adult ATLL (Giam and Pasupala, 2022).